Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,195 | -13,580 | -110,559 | -182,024 | -220,683 |
| Depreciation Amortization | 2,392 | 1,310 | 1,499 | 2,355 | 4,257 |
| Accounts receivable | -10,706 | -18,744 | -8,088 | -16,550 | 6,351 |
| Accounts payable and accrued liabilities | -2,715 | 8,469 | 15 | -578 | 3,278 |
| Other Working Capital | -31,880 | -27,603 | 16,790 | -10,506 | -35,079 |
| Other Operating Activity | 35,513 | 27,619 | 41,554 | 60,391 | 38,522 |
| Operating Cash Flow | $-27,591 | $-22,529 | $-58,789 | $-146,912 | $-203,354 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,228 | 20,393 | 19,527 | -1,726 | 35,719 |
| PPE Investments | -219 | -1,679 | -1,532 | -1,598 | -2,990 |
| Investing Cash Flow | $16,009 | $18,714 | $17,995 | $-3,324 | $32,729 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 137,245 | N/A | 24,350 | N/A | 148,963 |
| Common Stock Issued | 19,320 | 940 | 29,756 | 75,059 | 7,065 |
| Other Financing Activity | -142,138 | 0 | 1 | 0 | 0 |
| Financing Cash Flow | $14,427 | $940 | $54,107 | $75,059 | $156,028 |
| Beginning Cash Position | 25,802 | 28,677 | 15,364 | 90,541 | 105,138 |
| End Cash Position | 28,647 | 25,802 | 28,677 | 15,364 | 90,541 |
| Net Cash Flow | $2,845 | $-2,875 | $13,313 | $-75,177 | $-14,597 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,591 | -22,529 | -58,789 | -146,912 | -203,354 |
| Capital Expenditure | -317 | -1,706 | -1,545 | -1,825 | -3,022 |
| Free Cash Flow | -27,908 | -24,235 | -60,334 | -148,737 | -206,376 |